Studies have demonstrated that reintroducing wt-BRG1 into mutant (mt)-BRG1 tumor cell lines leads to re-expression of silenced genes and downregulation of genes that are overexpressed during NSCLC growth [59]. The gene discussed is SMARCA4; the disease is neoplasm.